Type 2 Diabetes With Obesity: Correcting the Biases

Sean Wharton, MD, PharmD

Disclosures

February 28, 2023

Sean Wharton, MD, PharmD, explores the topic of disparities in the treatment of type 2 diabetes with obesity within marginalized populations.

Such disparities, Dr Wharton holds, are most likely grounded in unconscious biases that lead to both underdiagnosis and undertreatment in these patients. Dr Wharton goes on to encourage a heightened awareness on the part of healthcare practitioners as a corrective to this enduring problem.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....